Drug Endocrinology

Azmiro

Payments companies reported to CMS as associated with Azmiro. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$30Kassociated payments (2023-2025)
1,208clinicians with associated payments
1company reporting

By year

2024 $266
2025 $30K

Payments reported as associated with Azmiro, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Urology $9,051
Family $4,333
Family Medicine $3,570
Physician Assistant $3,033
Internal Medicine $2,972
Endocrinology, Diabetes & Metabolism $1,439

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Azmiro

These are the largest totals companies reported as associated with Azmiro. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Rigoberto Franco Miami, FL Internal Medicine $135.60
Darren Bruck Doral, FL Urology $117.36
Miguel Castillo Santiago Houston, TX Family $103.67
Francisco Gelpi-Hammerschmidt Houston, TX Urology $102.97
Gregory Hester Houston, TX Urology $101.19
Diana Duran Marion, OH Family $96.07
Evan Appelbaum Chestnut Hill, MA Cardiovascular Disease $94.70
Paul Plante Columbia, SC Internal Medicine $88.75
Nora Kurbaj Beverly, MA Physician Assistant $86.24
James Ebertowski Willamsburgh, VA Urology $85.41

Prescribed Azmiro?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.